These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30200102)

  • 21. Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-β induction in patients with COPD.
    Tang W; Shen Z; Guo J; Sun S
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2951-2964. PubMed ID: 27932875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The lncRNA
    Liu S; Liu Y; Lu Q; Zhou X; Chen L; Liang W
    Onco Targets Ther; 2018; 11():6845-6851. PubMed ID: 30349317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA LUCAT1 promotes proliferation of ovarian cancer cells by regulating miR-199a-5p expression.
    Liu HZ; Liu GY; Pang WW; Zhang H; Zeng ZJ; Wang HJ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1682-1687. PubMed ID: 32141534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Long Non-Coding RNA TUG1 Promotes Colon Cancer Progression.
    Zhai HY; Sui MH; Yu X; Qu Z; Hu JC; Sun HQ; Zheng HT; Zhou K; Jiang LX
    Med Sci Monit; 2016 Sep; 22():3281-7. PubMed ID: 27634385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA LINC00152 is up-regulated in ovarian cancer tissues and regulates proliferation and cell cycle of SKOV3 cells.
    Ni H; Niu LL; Tian SC; Jing LK; Zhang LT; Lin QQ; Cai YH; Liang HM; Du Q; Li H
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9803-9813. PubMed ID: 31799647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
    Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
    Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
    Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. lncRNA TUG1 regulates Smac/DIABLO expression by competitively inhibiting miR-29b and modulates the apoptosis of lens epithelial cells in age-related cataracts.
    Sun M; Li K; Li X; Wang H; Li L; Zheng G
    Chin Med J (Engl); 2023 Oct; 136(19):2340-2350. PubMed ID: 37185343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C; Chen B; Wu B; Guo J; Cao Y
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncSOX4 serves an oncogenic role in the tumorigenesis of epithelial ovarian cancer by promoting cell proliferation and inhibiting apoptosis.
    Liu Y; Wang Y; Yao D; Cui D
    Mol Med Rep; 2018 Jun; 17(6):8282-8288. PubMed ID: 29693704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNA ABCB10 promotes cell proliferation and invasion, but inhibits apoptosis via regulating the microRNA‑1271‑mediated Capn4/Wnt/β‑catenin signaling pathway in epithelial ovarian cancer.
    Lin X; Chen Y; Ye X; Xia X
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
    Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA TUG1 regulates ovarian cancer proliferation and metastasis via affecting epithelial-mesenchymal transition.
    Kuang D; Zhang X; Hua S; Dong W; Li Z
    Exp Mol Pathol; 2016 Oct; 101(2):267-273. PubMed ID: 27693324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA TUG1 promotes bladder cancer malignant behaviors by regulating the miR-320a/FOXQ1 axis.
    Tan J; Liu B; Zhou L; Gao J; Wang XK; Liu Y; Wang JR
    Cell Signal; 2022 Mar; 91():110216. PubMed ID: 34920123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MicroRNA-16 regulates the proliferation, invasion and apoptosis of ovarian epithelial carcinoma cells in vitro].
    Tang R; Cui ZM; Lou YH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):846-50. PubMed ID: 23302126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
    Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
    Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA TUG1 regulates proliferation and apoptosis by regulating miR-148b/IGF2 axis in ox-LDL-stimulated VSMC and HUVEC.
    Wu X; Zheng X; Cheng J; Zhang K; Ma C
    Life Sci; 2020 Feb; 243():117287. PubMed ID: 31926240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145.
    Lei H; Gao Y; Xu X
    Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):588-597. PubMed ID: 28645161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.